Literature DB >> 6697121

Relative effects of ileal resection and bypass on intestinal adaptation and carcinogenesis.

J B Rainey, P W Davies, R C Williamson.   

Abstract

Since ileal resection and ileal bypass are commonly performed in man and might stimulate colonic hyperplasia, their co-carcinogenic potential was explored in male Sprague-Dawley rats (n = 135). One week after 33 per cent distal small-bowel resection, 33 per cent distal small-bowel bypass or distal ileal transection (control), animals started a 6-week course of azoxymethane injections (total dose 90 mg/kg ip). Findings in rats killed at 20 and 25 weeks were similar: bypass produced a higher yield of colorectal tumours (4.0 +/- 0.6 per rat: mean +/- s.e.) than controls (2.4 +/- 0.4; P less than 0.05), but resection caused maximal enhancement (5.2 +/- 0.5: P less than 0.01). In rats killed at 30 weeks, however, tumour yields were almost identical. Overall, resection increased colonic tumour yield by 55 per cent (P less than 0.02) and bypass by 32 per cent. Stathmokinetic measurements of crypt cell production rate (CCPR) at 20 weeks showed similar increases after resection and bypass both in residual functioning small bowel (109-200 per cent: P less than 0.01) and in colorectum (63-100 per cent: P less than 0.05). At 30 weeks these adaptive effects persisted, despite an overall increase in CCPR with age. Loss of functioning ileum enhances experimental colorectal carcinogenesis principally by reducing the latent period for tumour development. Resection has a greater effect than bypass probably by producing earlier hyperplasia, though later adaptive effects are similar.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697121     DOI: 10.1002/bjs.1800710309

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferation.

Authors:  G H Barsoum; H Thompson; J P Neoptolemos; M R Keighley
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

2.  Experimental colonic carcinogenesis: changes in faecal bile acids after promotion of intestinal tumours by small bowel resection in the rat.

Authors:  A P Savage; M S Sian; J L Matthews; S R Bloom; T Cooke
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

4.  Enteroglucagon and experimental intestinal carcinogenesis in the rat.

Authors:  A P Savage; J L Matthews; M A Ghatei; T Cooke; S R Bloom
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

5.  Validation of organ culture in colonic adaptation to surgical manipulation.

Authors:  G V Appleton; E E Wheeler; D N Challacombe; R C Williamson
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis.

Authors:  M G Thomas; K P Nugent; A Forbes; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

7.  Luminal and humoral influences on human rectal epithelial cytokinetics.

Authors:  M G Thomas
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

8.  Enhancing effect of partial gastrectomy on pancreatic carcinogenesis.

Authors:  P Watanapa; B Flaks; H Oztas; P H Deprez; J Calam; R C Williamson
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

9.  Colon adenocarcinoma after jejunoileal bypass for morbid obesity.

Authors:  Lee Morris; Ilimbek Beketaev; Roberto Barrios; Patrick Reardon
Journal:  J Surg Case Rep       Date:  2017-11-16

10.  Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.

Authors:  Sorena Afshar; Fiona Malcomson; Seamus B Kelly; Keith Seymour; Sean Woodcock; John C Mathers
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.